Abstract
Summary
Preclinical In-vivo Imaging System is a collective name for various types of remote sensor systems that acquire non-photographic remote sensing images of ground objects. Scanning is usually used to allow the observer to observe the conditions in the human or animal body.
LPI (LP Information)' newest research report, the “Preclinical In-vivo Imaging System Industry Forecast” looks at past sales and reviews total world Preclinical In-vivo Imaging System sales in 2022, providing a comprehensive analysis by region and market sector of projected Preclinical In-vivo Imaging System sales for 2023 through 2029. With Preclinical In-vivo Imaging System sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Preclinical In-vivo Imaging System industry.
This Insight Report provides a comprehensive analysis of the global Preclinical In-vivo Imaging System landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Preclinical In-vivo Imaging System portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Preclinical In-vivo Imaging System market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Preclinical In-vivo Imaging System and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Preclinical In-vivo Imaging System.
The global Preclinical In-vivo Imaging System market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Preclinical In-vivo Imaging System is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Preclinical In-vivo Imaging System is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Preclinical In-vivo Imaging System is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Preclinical In-vivo Imaging System players cover Siemens A.G., General Electric(GE), Agilent Technologies, FUJIFILM VisualSonics, Aspect Imaging, Biospace Lab SA, Bruker Corporation, LI-COR Biosciences and Mesoso Ltd., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Preclinical In-vivo Imaging System market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Optical Imaging System
Nuclear Imaging System
Micro MRI System
Micro CT System
Micro Ultrasound System
Photoacoustic and Magnetic Particle Imaging Systems
Segmentation by application
Hospitals
Veterinary Clinics
Laboratory
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Siemens A.G.
General Electric(GE)
Agilent Technologies
FUJIFILM VisualSonics
Aspect Imaging
Biospace Lab SA
Bruker Corporation
LI-COR Biosciences
Mesoso Ltd.
MIlabs BV
MR Solutions Ltd
PerkinElmer
TriFoil Imaging
Key Questions Addressed in this Report
What is the 10-year outlook for the global Preclinical In-vivo Imaging System market?
What factors are driving Preclinical In-vivo Imaging System market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Preclinical In-vivo Imaging System market opportunities vary by end market size?
How does Preclinical In-vivo Imaging System break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
LPI (LP Information)' newest research report, the “Preclinical In-vivo Imaging System Industry Forecast” looks at past sales and reviews total world Preclinical In-vivo Imaging System sales in 2022, providing a comprehensive analysis by region and market sector of projected Preclinical In-vivo Imaging System sales for 2023 through 2029. With Preclinical In-vivo Imaging System sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Preclinical In-vivo Imaging System industry.
This Insight Report provides a comprehensive analysis of the global Preclinical In-vivo Imaging System landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Preclinical In-vivo Imaging System portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Preclinical In-vivo Imaging System market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Preclinical In-vivo Imaging System and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Preclinical In-vivo Imaging System.
The global Preclinical In-vivo Imaging System market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Preclinical In-vivo Imaging System is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Preclinical In-vivo Imaging System is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Preclinical In-vivo Imaging System is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Preclinical In-vivo Imaging System players cover Siemens A.G., General Electric(GE), Agilent Technologies, FUJIFILM VisualSonics, Aspect Imaging, Biospace Lab SA, Bruker Corporation, LI-COR Biosciences and Mesoso Ltd., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Preclinical In-vivo Imaging System market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Optical Imaging System
Nuclear Imaging System
Micro MRI System
Micro CT System
Micro Ultrasound System
Photoacoustic and Magnetic Particle Imaging Systems
Segmentation by application
Hospitals
Veterinary Clinics
Laboratory
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Siemens A.G.
General Electric(GE)
Agilent Technologies
FUJIFILM VisualSonics
Aspect Imaging
Biospace Lab SA
Bruker Corporation
LI-COR Biosciences
Mesoso Ltd.
MIlabs BV
MR Solutions Ltd
PerkinElmer
TriFoil Imaging
Key Questions Addressed in this Report
What is the 10-year outlook for the global Preclinical In-vivo Imaging System market?
What factors are driving Preclinical In-vivo Imaging System market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Preclinical In-vivo Imaging System market opportunities vary by end market size?
How does Preclinical In-vivo Imaging System break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Preclinical In-vivo Imaging System Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Preclinical In-vivo Imaging System by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Preclinical In-vivo Imaging System by Country/Region, 2018, 2022 & 2029
2.2 Preclinical In-vivo Imaging System Segment by Type
2.2.1 Optical Imaging System
2.2.2 Nuclear Imaging System
2.2.3 Micro MRI System
2.2.4 Micro CT System
2.2.5 Micro Ultrasound System
2.2.6 Photoacoustic and Magnetic Particle Imaging Systems
2.3 Preclinical In-vivo Imaging System Sales by Type
2.3.1 Global Preclinical In-vivo Imaging System Sales Market Share by Type (2018-2023)
2.3.2 Global Preclinical In-vivo Imaging System Revenue and Market Share by Type (2018-2023)
2.3.3 Global Preclinical In-vivo Imaging System Sale Price by Type (2018-2023)
2.4 Preclinical In-vivo Imaging System Segment by Application
2.4.1 Hospitals
2.4.2 Veterinary Clinics
2.4.3 Laboratory
2.4.4 Other
2.5 Preclinical In-vivo Imaging System Sales by Application
2.5.1 Global Preclinical In-vivo Imaging System Sale Market Share by Application (2018-2023)
2.5.2 Global Preclinical In-vivo Imaging System Revenue and Market Share by Application (2018-2023)
2.5.3 Global Preclinical In-vivo Imaging System Sale Price by Application (2018-2023)
3 Global Preclinical In-vivo Imaging System by Company
3.1 Global Preclinical In-vivo Imaging System Breakdown Data by Company
3.1.1 Global Preclinical In-vivo Imaging System Annual Sales by Company (2018-2023)
3.1.2 Global Preclinical In-vivo Imaging System Sales Market Share by Company (2018-2023)
3.2 Global Preclinical In-vivo Imaging System Annual Revenue by Company (2018-2023)
3.2.1 Global Preclinical In-vivo Imaging System Revenue by Company (2018-2023)
3.2.2 Global Preclinical In-vivo Imaging System Revenue Market Share by Company (2018-2023)
3.3 Global Preclinical In-vivo Imaging System Sale Price by Company
3.4 Key Manufacturers Preclinical In-vivo Imaging System Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Preclinical In-vivo Imaging System Product Location Distribution
3.4.2 Players Preclinical In-vivo Imaging System Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Preclinical In-vivo Imaging System by Geographic Region
4.1 World Historic Preclinical In-vivo Imaging System Market Size by Geographic Region (2018-2023)
4.1.1 Global Preclinical In-vivo Imaging System Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Preclinical In-vivo Imaging System Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Preclinical In-vivo Imaging System Market Size by Country/Region (2018-2023)
4.2.1 Global Preclinical In-vivo Imaging System Annual Sales by Country/Region (2018-2023)
4.2.2 Global Preclinical In-vivo Imaging System Annual Revenue by Country/Region (2018-2023)
4.3 Americas Preclinical In-vivo Imaging System Sales Growth
4.4 APAC Preclinical In-vivo Imaging System Sales Growth
4.5 Europe Preclinical In-vivo Imaging System Sales Growth
4.6 Middle East & Africa Preclinical In-vivo Imaging System Sales Growth
5 Americas
5.1 Americas Preclinical In-vivo Imaging System Sales by Country
5.1.1 Americas Preclinical In-vivo Imaging System Sales by Country (2018-2023)
5.1.2 Americas Preclinical In-vivo Imaging System Revenue by Country (2018-2023)
5.2 Americas Preclinical In-vivo Imaging System Sales by Type
5.3 Americas Preclinical In-vivo Imaging System Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Preclinical In-vivo Imaging System Sales by Region
6.1.1 APAC Preclinical In-vivo Imaging System Sales by Region (2018-2023)
6.1.2 APAC Preclinical In-vivo Imaging System Revenue by Region (2018-2023)
6.2 APAC Preclinical In-vivo Imaging System Sales by Type
6.3 APAC Preclinical In-vivo Imaging System Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Preclinical In-vivo Imaging System by Country
7.1.1 Europe Preclinical In-vivo Imaging System Sales by Country (2018-2023)
7.1.2 Europe Preclinical In-vivo Imaging System Revenue by Country (2018-2023)
7.2 Europe Preclinical In-vivo Imaging System Sales by Type
7.3 Europe Preclinical In-vivo Imaging System Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Preclinical In-vivo Imaging System by Country
8.1.1 Middle East & Africa Preclinical In-vivo Imaging System Sales by Country (2018-2023)
8.1.2 Middle East & Africa Preclinical In-vivo Imaging System Revenue by Country (2018-2023)
8.2 Middle East & Africa Preclinical In-vivo Imaging System Sales by Type
8.3 Middle East & Africa Preclinical In-vivo Imaging System Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Preclinical In-vivo Imaging System
10.3 Manufacturing Process Analysis of Preclinical In-vivo Imaging System
10.4 Industry Chain Structure of Preclinical In-vivo Imaging System
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Preclinical In-vivo Imaging System Distributors
11.3 Preclinical In-vivo Imaging System Customer
12 World Forecast Review for Preclinical In-vivo Imaging System by Geographic Region
12.1 Global Preclinical In-vivo Imaging System Market Size Forecast by Region
12.1.1 Global Preclinical In-vivo Imaging System Forecast by Region (2024-2029)
12.1.2 Global Preclinical In-vivo Imaging System Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Preclinical In-vivo Imaging System Forecast by Type
12.7 Global Preclinical In-vivo Imaging System Forecast by Application
13 Key Players Analysis
13.1 Siemens A.G.
13.1.1 Siemens A.G. Company Information
13.1.2 Siemens A.G. Preclinical In-vivo Imaging System Product Portfolios and Specifications
13.1.3 Siemens A.G. Preclinical In-vivo Imaging System Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Siemens A.G. Main Business Overview
13.1.5 Siemens A.G. Latest Developments
13.2 General Electric(GE)
13.2.1 General Electric(GE) Company Information
13.2.2 General Electric(GE) Preclinical In-vivo Imaging System Product Portfolios and Specifications
13.2.3 General Electric(GE) Preclinical In-vivo Imaging System Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 General Electric(GE) Main Business Overview
13.2.5 General Electric(GE) Latest Developments
13.3 Agilent Technologies
13.3.1 Agilent Technologies Company Information
13.3.2 Agilent Technologies Preclinical In-vivo Imaging System Product Portfolios and Specifications
13.3.3 Agilent Technologies Preclinical In-vivo Imaging System Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Agilent Technologies Main Business Overview
13.3.5 Agilent Technologies Latest Developments
13.4 FUJIFILM VisualSonics
13.4.1 FUJIFILM VisualSonics Company Information
13.4.2 FUJIFILM VisualSonics Preclinical In-vivo Imaging System Product Portfolios and Specifications
13.4.3 FUJIFILM VisualSonics Preclinical In-vivo Imaging System Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 FUJIFILM VisualSonics Main Business Overview
13.4.5 FUJIFILM VisualSonics Latest Developments
13.5 Aspect Imaging
13.5.1 Aspect Imaging Company Information
13.5.2 Aspect Imaging Preclinical In-vivo Imaging System Product Portfolios and Specifications
13.5.3 Aspect Imaging Preclinical In-vivo Imaging System Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Aspect Imaging Main Business Overview
13.5.5 Aspect Imaging Latest Developments
13.6 Biospace Lab SA
13.6.1 Biospace Lab SA Company Information
13.6.2 Biospace Lab SA Preclinical In-vivo Imaging System Product Portfolios and Specifications
13.6.3 Biospace Lab SA Preclinical In-vivo Imaging System Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Biospace Lab SA Main Business Overview
13.6.5 Biospace Lab SA Latest Developments
13.7 Bruker Corporation
13.7.1 Bruker Corporation Company Information
13.7.2 Bruker Corporation Preclinical In-vivo Imaging System Product Portfolios and Specifications
13.7.3 Bruker Corporation Preclinical In-vivo Imaging System Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Bruker Corporation Main Business Overview
13.7.5 Bruker Corporation Latest Developments
13.8 LI-COR Biosciences
13.8.1 LI-COR Biosciences Company Information
13.8.2 LI-COR Biosciences Preclinical In-vivo Imaging System Product Portfolios and Specifications
13.8.3 LI-COR Biosciences Preclinical In-vivo Imaging System Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 LI-COR Biosciences Main Business Overview
13.8.5 LI-COR Biosciences Latest Developments
13.9 Mesoso Ltd.
13.9.1 Mesoso Ltd. Company Information
13.9.2 Mesoso Ltd. Preclinical In-vivo Imaging System Product Portfolios and Specifications
13.9.3 Mesoso Ltd. Preclinical In-vivo Imaging System Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Mesoso Ltd. Main Business Overview
13.9.5 Mesoso Ltd. Latest Developments
13.10 MIlabs BV
13.10.1 MIlabs BV Company Information
13.10.2 MIlabs BV Preclinical In-vivo Imaging System Product Portfolios and Specifications
13.10.3 MIlabs BV Preclinical In-vivo Imaging System Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 MIlabs BV Main Business Overview
13.10.5 MIlabs BV Latest Developments
13.11 MR Solutions Ltd
13.11.1 MR Solutions Ltd Company Information
13.11.2 MR Solutions Ltd Preclinical In-vivo Imaging System Product Portfolios and Specifications
13.11.3 MR Solutions Ltd Preclinical In-vivo Imaging System Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 MR Solutions Ltd Main Business Overview
13.11.5 MR Solutions Ltd Latest Developments
13.12 PerkinElmer
13.12.1 PerkinElmer Company Information
13.12.2 PerkinElmer Preclinical In-vivo Imaging System Product Portfolios and Specifications
13.12.3 PerkinElmer Preclinical In-vivo Imaging System Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 PerkinElmer Main Business Overview
13.12.5 PerkinElmer Latest Developments
13.13 TriFoil Imaging
13.13.1 TriFoil Imaging Company Information
13.13.2 TriFoil Imaging Preclinical In-vivo Imaging System Product Portfolios and Specifications
13.13.3 TriFoil Imaging Preclinical In-vivo Imaging System Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 TriFoil Imaging Main Business Overview
13.13.5 TriFoil Imaging Latest Developments
14 Research Findings and Conclusion